PNP Drug Mechanisms Flashcards
Tetrodotoxin (TTX)
Presynaptic neuromuscular agent
blocks voltage gated Na channels
Mg2+, cations
presynaptic agent
competition/blocker of ca2+ channels
aminoglycosides
presynaptic agent
reduces Ca entry through channels
Note: do not use these antibiotics with myasthenia gravis patients
black widow spider venom
a-latrotoxin
presynaptic agent
adds Ca channels to membrane, leads to barrage and exocytosis creating loss of Ach vesicles and increased surface area (results in transmission block)
botulinum toxin A
presynaptic agent
cleaves SNAP-25 (SNARE complex), reducing calcium sensitivity and preventing secretion
Note: blocks ANS as well, not just muscles
botulinum toxin B
presynaptic agent
cleaves synaptobrevin SNARE protein
hemicholinium
presynaptic agent
interferes with choline uptake, leads to less Ach available for secretion
tubocurarine
postsynaptic non-depolarizing blocker
competitive inhibition of Ach at nicotinic receptors
pancuronium
postsynaptic non-depolarizing blocker
competitive inhibition of Ach, selective for neuromuscular junction
Note: do not use with aminoglycosides (similar to MG)
Note: renal clearance
vecuronium
postsynaptic non-depolarizing blocker
competitive inhibition of Ach, similar to pancuronium but faster action (intermediate duration)
Note: no CV effects, eliminated by liver
rocuronium
postsynaptic non-depolarizing blocker
competitive inhibition of Ach
Note: very rapid onset, similar duration to vecuronium
acetylcholine
post-synaptic depolarizing blocker
nicotinic receptor agonist, can block at high exogenous concentrations
succinylcholine
post-synaptic depolarizing blocker
nicotinic receptor agonist, causes sustained depolarization/desensitization
Notes: rapidly reversible, can cause muscle fasciculations and damage, hydrolyzed by cholinesterases
nicotine
post-synaptic depolarizing blocker
depolarizing blocker at neuromuscular junction
sugummadex
reversal agent of non-depolarizing blocker
encapsulates blockers to eliminate actions (specifically rocuronium, vecuronium)
neostigmine
anti-cholinesterase
binds to cholinesterase to prevent degradation
edrophonium
anti-cholinesterase
binds to cholinesterase, short-acting and rapid onset
physostigmine
anti-cholinesterase
Notes: can cross BBB
pyridostigmine bromide
anti-cholinesterase
neostigmine but long lasting slow release form
DFP
anti-cholinesterase
irreversible phosphorylation of esteratic site of acetylcholinesterase
Notes: well absorbed in all routes
sarin
anti-cholinesterase
irreversible phosphorylation of esteratic site of acetylcholinesterase
parathion
anti-cholinesterase
irreversible phosphorylation of esteratic site of acetylcholinesterase
Notes: metabolized into a toxic form that inhibits ChE
malathion
anti-cholinesterase
irreversible phosphorylation of esteratic site of acetylcholinesterase
Notes: slightly safer than malathion (easier metabolism)
chlorpyifos
anti-cholinesterase
irreversible phosphorylation of esteratic site of acetylcholinesterase
VX
anti-cholinesterase
irreversible phosphorylation of esteratic site of acetylcholinesterase
Notes: almost impossible to remove, deadliest of nerve gases
rivastigmine, galantamine, donepezil, tacrine
anti-cholinesterase
cholinesterase inhibitor
oximes, pralidoxime
anticholinesterase antagonist
remotes phosphorylation from ache to restore cholinesterase activity
dantrolene
peripheral muscle relaxant
ryanodine receptor blocker, preventing release of Ca
methacholine
parasympathomimetic
muscarinic receptor agonist
bethanechol
parasympathomimetic
muscarinic receptor agonist
Notes: resistant to hydrolysis by cholinesterases
pilocarpine
parasympathomimetic
muscarinic receptor agonist
Notes: not hydrolyzed by cholinesterases
cevimeline
parasympathomimetic
muscarinic receptor agonist
Notes: only used in Sjogren’s
atropine
muscarinic receptor blocker
competitive inhibitor of Ach at muscarinic receptors
Notes: associated with toxicity syndrome
homatropine
muscarinic receptor blocker
competitive inhibitor of Ach at muscarinic receptors, like atropine but shorter acting
scopolamine
muscarinic receptor blocker
competitive inhibitor of Ach at muscarinic receptors
Notes: causes more CNS depressant effects compared to atropine
glycopyrrolate
muscarinic receptor blocker
Notes: prevents excessive muscarinic effects after removal of blocker
tolterodine
muscarinic receptor blocker
Notes: has active metabolite
fesoterodine
muscarinic receptor blocker
Notes: needs to be metabolized to active version
solifenacin
muscarinic receptor blocker
like tolterodine but better
darifenacin
muscarinic receptor blocker
oxybutynin
muscarinic receptor blocker
tropicamide
muscarinic receptor blocker
ocular effects
ipratropium
muscarinic receptor blocker
SAMA, bronchiolar dilation, blocks both presynaptic inhibitory and postsynaptics
tiotropium
muscarinic receptor blocker
LAMA, bronchiolar dilation, more effective than ipratropium (postysnaptics only)
norepinephrine
non-selective adrenergic agonist
activity: all a, B1, B3
No B2
epinephrine
non-selective adrenergic agonist
activity: all a and B
notes: metabolized by MAO
isoproterenol
non-selective adrenergic agonist
activity: all B, No a
phenylephrine
selective a1 agonist
longer duration than epi,, selective but not potent
imidazolines
selective a1 agonist
long acting
Notes: may cause depressant effects in kids